Cleared Traditional

K962627 - CLINICAL PHOSPHORUS SPECTROSCOPY OPTION...

K962627 is the FDA 510(k) clearance for CLINICAL PHOSPHORUS SPECTROSCOPY OPTION... by Siemens Medical Solutions USA, Inc.. It is a Class 2 Radiology device (product code LNI) cleared through the Traditional 510(k) pathway after a 272-day FDA review.

K962627 · Siemens Medical Solutions USA, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
272d
Days
Class 2
Risk

K962627 is an FDA 510(k) clearance for the CLINICAL PHOSPHORUS SPECTROSCOPY OPTION/MAGNETOM VISION SYSTEM. Classified as System, Nuclear Magnetic Resonance Spectroscopic (product code LNI), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Iselin, US). The FDA issued a Cleared decision on April 3, 1997 after a review of 272 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Medical Solutions USA, Inc. devices

Submission Details

510(k) Number K962627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 1996
Decision Date April 03, 1997
Days to Decision 272 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
165d slower than avg
Panel avg: 107d · This submission: 272d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNI System, Nuclear Magnetic Resonance Spectroscopic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNI System, Nuclear Magnetic Resonance Spectroscopic

All 9
Devices cleared under the same product code (LNI) and FDA review panel - the closest regulatory comparables to K962627.
MODIFICATION TO 3.0T SIGNA VH/I MAGNETIC RESONANCE SYSTEM
K003575 · GE Medical Systems · Jan 2001
MR SPECTROSCOPY PACKAGE
K991568 · Philips Medical Systems (Cleveland), Inc. · Jul 1999
SAGE 7
K984167 · GE Medical Systems · Jan 1999
GYREX 2T-PRESTIGE
K970005 · Elscint, Inc. · Mar 1997
HYDROGEN SPECTROSCOPY OPTION-PROBE #M1040HS/HT
K930265 · GE Medical Systems · Apr 1995